Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA FY 2024 Budget Includes 10% Funding Boost, But No Movement On Diagnostics

Mar 10 2023

• By Hannah Daniel

• Source: Shutterstock

Related Content

Teamwork: FDA And NIH Join Forces To Fund Neurodegenerative Disease Research, Medical Device Development Tools

Sep 20 2022

Diagnostics Reform Out As Congress Reaches Year-End Omnibus Compromise

Dec 20 2022

FDA’s FY 2023 Proposed Budget Asks For Millions To Curb Device Shortages, Bolster Cybersecurity, And More

Mar 28 2022

Office of Digital Transformation’s 2022 Year In Review: The MAP To Success

Jan 04 2023

'All Options On The Table,' Says Hillebrenner On Diagnostics Reform

Feb 23 2023

Biden Shouts Out ‘Cancer Moonshot’ In State Of The Union

Feb 08 2023

So The Public Health Emergency Is Over. Now What?

Feb 28 2023

Additional Topics

United States FDA Policy Supply Chain Innovation Medical Device Diagnostics

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window